Cervical Cancer
Conditions
Interventions
Single-dose group:None
Multiple-dose group:None
Sponsors
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Eligibility
Sex/Gender
Female
Age
9 Years to 20 Years
Inclusion criteria
Inclusion criteria: (1) Permanent residents in study sites (2) Females (3) The age of enrollment is 9-20 years old (4) The study participants and their parents/legal guardians (applicable to participants aged 9-18 years) are able to understand the requirements mentioned in the study protocol (5) Written informed consent obtained from the study participants and their parents/legal guardians (applicable to participants aged 9-18 years)
Exclusion criteria
Exclusion criteria: Autoimmune diseases, malignant tumor history, or other severe diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Seropositivity rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Antibody Geometric Mean Titer;B/T lymphocyte response level;Antibody affinity; | — |
Countries
China
Contacts
Public ContactFanghui Zhao
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Outcome results
None listed